Open Access. Powered by Scholars. Published by Universities.®
- Discipline
Articles 1 - 3 of 3
Full-Text Articles in Mathematics
Hypersurfaces In Hyperbolic Space With Support Function, Vincent Bonini, José M. Espinar, Jie Qint
Hypersurfaces In Hyperbolic Space With Support Function, Vincent Bonini, José M. Espinar, Jie Qint
Mathematics
Based on [previous publication*], we develop a global correspondence between immersed hypersurfaces ϕ:Mn→Hn+1ϕ:Mn→Hn+1 satisfying an exterior horosphere condition, also called here horospherically concave hypersurfaces, and complete conformal metrics e2ρgSne2ρgSn on domains Ω in the boundary SnSn at infinity of Hn+1Hn+1, where ρ is the horospherical support function, ∂∞ϕ(Mn)=∂Ω∂∞ϕ(Mn)=∂Ω, and Ω is the image of the Gauss map G:Mn→SnG:Mn→Sn. To do so we first establish results on when the Gauss map G:Mn→SnG:Mn→Sn is injective. We also …
Smooth Representation Of Functions On Non-Periodic Domains By Means Of The Fourier Continuation Method, Nicholas Rubel, David Bilyeu, Justin Koo
Smooth Representation Of Functions On Non-Periodic Domains By Means Of The Fourier Continuation Method, Nicholas Rubel, David Bilyeu, Justin Koo
STAR Program Research Presentations
This report examines a new methodology in solving Partial Differential Equations (PDEs) numerically. The report also studies the accuracy of this new method as a PDE solver. This new Fourier Continuation (FC) method is one of a few that avoids the well-known Gibbs Phenomenon, which is the overestimation or underestimation of a function. These estimations are oscillations around a “jump” when a non-periodic function is expressed in terms of sines and cosines. Instead, the FC algorithm creates a smooth, periodic extension of a function over a general domain, as demonstrated by the many examples presented here. The FC algorithm was …
An Analysis Of Strategic Treatment Interruptions During Imatinib Treatment Of Chronic Myelogenous Leukemia With Imatinib-Resistant Mutations, Dana Paquin, David Sacco, John Shamshoian
An Analysis Of Strategic Treatment Interruptions During Imatinib Treatment Of Chronic Myelogenous Leukemia With Imatinib-Resistant Mutations, Dana Paquin, David Sacco, John Shamshoian
Mathematics
Chronic myelogenous leukemia (CML) is a cancer of the white blood cells that results from increased and uncontrolled growth of myeloid cells in the bone marrow and the accumulation of these cells in the blood. The most common form of treatment for CML is imatinib, a tyrosine kinase inhibitor. Although imatinib is an effective treatment for CML and most patients treated with imatinib do attain some form of remission, imatinib does not completely eradicate all leukemia cells, and if treatment is stopped, all patients eventually relapse (Cortes, 2005). In Kim (2008), the authors developed a mathematical model for the dynamics …